Topics

STAT Plus: UCB’s $2.5 billion purchase of Ra Pharma underscores immunology focus

11:25 EDT 11 Oct 2019 | STAT

Both companies have focused on immunology disorders, including myasthenia gravis, a rare and incurable autoimmune disease.

Original Article: STAT Plus: UCB’s $2.5 billion purchase of Ra Pharma underscores immunology focus

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: UCB’s $2.5 billion purchase of Ra Pharma underscores immunology focus"

Quick Search

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...